{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:01:41Z","timestamp":1790816501586,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type 2 diabetes (T2D) is characterized by metabolic derangements that cause a shift in substrate preference, inducing cardiac interstitial fibrosis. Interstitial fibrosis plays a key role in aggravating left ventricular diastolic dysfunction (LVDD), which has previously been associated with the asymptomatic onset of heart failure. The latter is responsible for 80% of deaths among diabetic patients and has been termed diabetic cardiomyopathy (DCM). Through in silico prediction and subsequent detection in a leptin receptor-deficient db\/db mice model (db\/db), we confirmed the presence of previously identified potential biomarkers to detect the early onset of DCM. Differential expression of Lysyl Oxidase Like 2 (<jats:italic>LOXL2<\/jats:italic>) and Electron Transfer Flavoprotein Beta Subunit (<jats:italic>ETF\u03b2<\/jats:italic>), in both serum and heart tissue of 6\u201316-week-old db\/db mice, correlated with a reduced left-ventricular diastolic dysfunction as assessed by high-resolution Doppler echocardiography. Principal component analysis of the combined biomarkers, <jats:italic>LOXL2<\/jats:italic> and <jats:italic>ETF\u03b2<\/jats:italic>, further displayed a significant difference between wild type and db\/db mice from as early as 9\u00a0weeks of age. Knockdown in H9c2 cells, utilising siRNA of either LOXL2 or ETF\u03b2, revealed a decrease in the expression of Collagen Type I Alpha1 (<jats:italic>COL1A1<\/jats:italic>), a marker known to contribute to enhanced myocardial fibrosis. Additionally, receiver-operating curve (ROC) analysis of the proposed diagnostic profile showed that the combination of <jats:italic>LOXL2<\/jats:italic> and <jats:italic>ETF\u03b2<\/jats:italic> resulted in an area under the curve (AUC) of 0.813, with a cut-off point of 0.824, thus suggesting the favorable positive predictive power of the model and further supporting the use of LOXL2 and <jats:italic>ETF\u03b2<\/jats:italic> as possible early predictive DCM biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-020-69254-x","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T10:05:06Z","timestamp":1595498706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model"],"prefix":"10.1038","volume":"10","author":[{"given":"Rabia","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xolisa","family":"Nxele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonhlakanipho","family":"Sangweni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Jooste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkanyiso","family":"Hadebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Samodien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mongi","family":"Benjeddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikateko","family":"Mazino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Louw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Lecour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"69254_CR1","unstructured":"IDF. International Diabetes Federation (IDF) Diabetes Atlas (9th Edition) Global fact sheet. 1\u20132 (2019)."},{"key":"69254_CR2","unstructured":"WHO. World Health Organization. Hypertensive Fact Sheet (2019)."},{"key":"69254_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler, S. et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30, 595\u2013602 (1972).","journal-title":"Am. J. Cardiol."},{"key":"69254_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13098-017-0225-1","volume":"9","author":"MC Bertoluci","year":"2017","unstructured":"Bertoluci, M. C. & Rocha, V. Z. Cardiovascular risk assessment in patients with diabetes. Diabetol. Metab. Syndr. 9, 25. https:\/\/doi.org\/10.1186\/s13098-017-0225-1 (2017).","journal-title":"Diabetol. Metab. Syndr."},{"key":"69254_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","volume":"18","author":"T Miki","year":"2013","unstructured":"Miki, T., Yuda, S., Kouzu, H. & Miura, T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail. Rev. 18, 149\u2013166. https:\/\/doi.org\/10.1007\/s10741-012-9313-3 (2013).","journal-title":"Heart Fail. Rev."},{"key":"69254_CR6","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/circulationaha.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina, S. & Abel, E. D. Diabetic cardiomyopathy revisited. Circulation 115, 3213\u20133223. https:\/\/doi.org\/10.1161\/circulationaha.106.679597 (2007).","journal-title":"Circulation"},{"key":"69254_CR7","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.bbadis.2017.03.013","volume":"2070\u20132077","author":"R Guo","year":"1863","unstructured":"Guo, R. & Nair, S. Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention. Biochem. Biophys. Acta. 2070\u20132077, 2017. https:\/\/doi.org\/10.1016\/j.bbadis.2017.03.013 (1863).","journal-title":"Biochem. Biophys. Acta."},{"key":"69254_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/er.2003-0012","volume":"25","author":"ZY Fang","year":"2004","unstructured":"Fang, Z. Y., Prins, J. B. & Marwick, T. H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25, 543\u2013567. https:\/\/doi.org\/10.1210\/er.2003-0012 (2004).","journal-title":"Endocr. Rev."},{"key":"69254_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3904\/kjim.2016.208","volume":"32","author":"WS Lee","year":"2017","unstructured":"Lee, W. S. & Kim, J. Diabetic cardiomyopathy: where we are and where we are going. Korean J. Int. Med. 32, 404\u2013421. https:\/\/doi.org\/10.3904\/kjim.2016.208 (2017).","journal-title":"Korean J. Int. Med."},{"key":"69254_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui, A. L., Horwich, T. B. & Fonarow, G. C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 8, 30\u201341. https:\/\/doi.org\/10.1038\/nrcardio.2010.165 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"69254_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"A Lorenzo-Almoros","year":"2017","unstructured":"Lorenzo-Almoros, A. et al. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc. Diabetol. 16, 28 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"69254_CR12","doi-asserted-by":"publisher","first-page":"6143129","DOI":"10.1155\/2016\/6143129","volume":"2016","author":"LE Leon","year":"2016","unstructured":"Leon, L. E., Rani, S., Fernandez, M., Larico, M. & Calligaris, S. D. Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives. J. Diabetes Res. 2016, 6143129. https:\/\/doi.org\/10.1155\/2016\/6143129 (2016).","journal-title":"J. Diabetes Res."},{"key":"69254_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2840-9-89","volume":"9","author":"S Romano","year":"2010","unstructured":"Romano, S. et al. Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc. Diabetol. 9, 89. https:\/\/doi.org\/10.1186\/1475-2840-9-89 (2010).","journal-title":"Cardiovasc. Diabetol."},{"key":"69254_CR14","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat. Commun. 7, 13710. https:\/\/doi.org\/10.1038\/ncomms13710 (2016).","journal-title":"Nat. Commun."},{"key":"69254_CR15","doi-asserted-by":"publisher","unstructured":"Zhao, Y. et al. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation. Biosci. Rep. 37. https:\/\/doi.org\/10.1042\/bsr20171332 (2017).","DOI":"10.1042\/bsr20171332"},{"key":"69254_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.toxlet.2015.02.012","volume":"234","author":"J Jiang","year":"2015","unstructured":"Jiang, J. et al. Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol. Lett. 234, 139\u2013150. https:\/\/doi.org\/10.1016\/j.toxlet.2015.02.012 (2015).","journal-title":"Toxicol. Lett."},{"key":"69254_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1074\/mcp.M700478-MCP200","volume":"7","author":"H Lu","year":"2008","unstructured":"Lu, H., Yang, Y., Allister, E. M., Wijesekara, N. & Wheeler, M. B. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol. Cell. Proteomics MCP 7, 1434\u20131451. https:\/\/doi.org\/10.1074\/mcp.M700478-MCP200 (2008).","journal-title":"Mol. Cell. Proteomics MCP"},{"key":"69254_CR18","doi-asserted-by":"publisher","first-page":"461967","DOI":"10.1155\/2013\/461967","volume":"2013","author":"O Lorenzo","year":"2013","unstructured":"Lorenzo, O., Ramirez, E., Picatoste, B., Egido, J. & Tunon, J. Alteration of energy substrates and ROS production in diabetic cardiomyopathy. Mediat. Inflamm. 2013, 461967. https:\/\/doi.org\/10.1155\/2013\/461967 (2013).","journal-title":"Mediat. Inflamm."},{"key":"69254_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11906-004-0035-3","volume":"6","author":"DD Belke","year":"2004","unstructured":"Belke, D. D. & Dillmann, W. H. Altered cardiac calcium handling in diabetes. Curr. Hypertens. Rep. 6, 424\u2013429 (2004).","journal-title":"Curr. Hypertens. Rep."},{"key":"69254_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0026-0495(00)90588-2","volume":"49","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K. et al. The db\/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metab. Clin. Exp. 49, 22\u201331 (2000).","journal-title":"Metab. Clin. Exp."},{"key":"69254_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbrc.2013.07.063","volume":"438","author":"T Inoue","year":"2013","unstructured":"Inoue, T. et al. Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db\/db mice. Biochem. Biophys. Res. Commun. 438, 224\u2013229. https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.063 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"69254_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00380-017-0978-3","volume":"32","author":"PV Dludla","year":"2017","unstructured":"Dludla, P. V. et al. Age-dependent development of left ventricular wall thickness in type 2 diabetic (db\/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels. Heart Vessels 32, 1025\u20131031. https:\/\/doi.org\/10.1007\/s00380-017-0978-3 (2017).","journal-title":"Heart Vessels"},{"key":"69254_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.12250","volume":"5","author":"Q Liu","year":"2014","unstructured":"Liu, Q., Wang, S. & Cai, L. Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J. Diabetes Invest.  5, 623\u2013634. https:\/\/doi.org\/10.1111\/jdi.12250 (2014).","journal-title":"J. Diabetes Invest."},{"key":"69254_CR24","doi-asserted-by":"publisher","first-page":"H934","DOI":"10.1152\/ajpheart.00238.2018","volume":"315","author":"L Alex","year":"2018","unstructured":"Alex, L., Russo, I., Holoborodko, V. & Frangogiannis, N. G. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction. Am. J. Physiol. Heart Circul. Physiol. 315, H934\u2013H949. https:\/\/doi.org\/10.1152\/ajpheart.00238.2018 (2018).","journal-title":"Am. J. Physiol. Heart Circul. Physiol."},{"key":"69254_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/cvr\/cvv214","volume":"109","author":"J Gonzalez-Santamaria","year":"2016","unstructured":"Gonzalez-Santamaria, J. et al. Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovasc. Res. 109, 67\u201378. https:\/\/doi.org\/10.1093\/cvr\/cvv214 (2016).","journal-title":"Cardiovasc. Res."},{"key":"69254_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/1061186x.2018.1550649","author":"L Chen","year":"2018","unstructured":"Chen, L., Li, S. & Li, W. LOX\/LOXL in pulmonary fibrosis: potential therapeutic targets. J. Drug Targeting https:\/\/doi.org\/10.1080\/1061186x.2018.1550649 (2018).","journal-title":"J. Drug Targeting"},{"key":"69254_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.18388\/abp.2014_1898","volume":"61","author":"D Karthik","year":"2014","unstructured":"Karthik, D., Vijayakumar, R., Pazhanichamy, K. & Ravikumar, S. A proteomics approach to identify the differential protein level in cardiac muscle of diabetic rat. Acta Biochim. Pol. 61, 285\u2013293 (2014).","journal-title":"Acta Biochim. Pol."},{"key":"69254_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2337\/db07-0481","volume":"56","author":"S Boudina","year":"2007","unstructured":"Boudina, S. et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 56, 2457\u20132466. https:\/\/doi.org\/10.2337\/db07-0481 (2007).","journal-title":"Diabetes"},{"key":"69254_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-017-4497-9","volume":"167","author":"S Ruiz-Pinto","year":"2018","unstructured":"Ruiz-Pinto, S. et al. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients. Breast Cancer Res. Treat. 167, 249\u2013256. https:\/\/doi.org\/10.1007\/s10549-017-4497-9 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"69254_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12933-015-0173-8","volume":"14","author":"J Fuentes-Antras","year":"2015","unstructured":"Fuentes-Antras, J. et al. Targeting metabolic disturbance in the diabetic heart. Cardiovasc. Diabetol. 14, 17. https:\/\/doi.org\/10.1186\/s12933-015-0173-8 (2015).","journal-title":"Cardiovasc. Diabetol."},{"key":"69254_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jdermsci.2011.08.003","volume":"64","author":"S Hirokawa","year":"2011","unstructured":"Hirokawa, S., Shimanuki, T., Kitajima, H., Nishimori, Y. & Shimosaka, M. Identification of ETFB as a candidate protein that participates in the mechanoregulation of fibroblast cell number in collagen gel culture. J. Dermatol. Sci. 64, 119\u2013126. https:\/\/doi.org\/10.1016\/j.jdermsci.2011.08.003 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"69254_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jdermsci.2012.09.012","volume":"68","author":"S Hirokawa","year":"2012","unstructured":"Hirokawa, S., Shimanuki, T., Kitajima, H., Nishimori, Y. & Shimosaka, M. Knockdown of electron transfer flavoprotein beta subunit reduced TGF-beta-induced alpha-SMA mRNA expression but not COL1A1 in fibroblast-populated three-dimensional collagen gel cultures. J. Dermatol. Sci. 68, 179\u2013186. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.09.012 (2012).","journal-title":"J. Dermatol. Sci."},{"key":"69254_CR33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/mnfr.201500656","volume":"60","author":"R Johnson","year":"2016","unstructured":"Johnson, R. et al. Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis. Mol. Nutr. Food Res. 60, 922\u2013934. https:\/\/doi.org\/10.1002\/mnfr.201500656 (2016).","journal-title":"Mol. Nutr. Food Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69254-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:31:51Z","timestamp":1670337111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69254"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69254-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12352"}}